Article Text

Download PDFPDF
Pilot study for the ‘Test n Treat’ trial of on-site rapid chlamydia/gonorrhoea tests and same day treatment
  1. Anjella Balendra1,
  2. Emma Cousins2,
  3. Helen Lamplough1,
  4. Pippa Oakeshott1,
  5. Wendy Majewska3,
  6. Sarah Ruth Kerry1
  1. 1Population Health Research Institute, St George's University of London, London, UK
  2. 2Applied Diagnostic Research Evaluation Unit (ADREU), Institute of Infection and Immunity, St George's University of London
  3. 3Institute of Infection and Immunity, St George's University of London, London, UK
  1. Correspondence to Dr Anjella Balendra, Population Health Research Institute, St George's University of London, Cranmer Terrace, London SW17 0RE, UK; anjella.balendra{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Outreach sexual health services usually target hard to reach, higher risk populations who are not accessing mainstream services. These include some black minority ethnic groups and young people.1 In May 2016, we carried out a pilot study in a Further Education (FE) college to explore the feasibility of providing rapid, on-site chlamydia/gonorrhoea testing with results within 2 hours, and same day treatment if required (‘Test n Treat’).

Consecutive students were approached and asked if they were willing to complete a questionnaire and provide a genitourinary sample for rapid chlamydia/gonorrhoea testing. Students who had never had sexual intercourse or were outside the 16–24 years age range were …

View Full Text


  • Contributors AB is a GPST4 and NIHR Academic Clinical Fellow in Primary Care. PO is academic supervisor to AB. PO and SRK designed the service evaluation pilot with advice from EC and WM; AB, HL and SRK collected and analysed the data. WM counselled students requiring treatment. AB and PO drafted and revised the article, and all authors approved the final version. AB is a guarantor.

  • Funding NIHR Research for Patient Benefit Programme, PB-PG-1014-35007.

  • Competing interests PO is a member of the NIHR South London Collaboration for Leadership in Applied Health Research and Care. PO and EC are members of the esti2 consortium funded under the UKCRC Translational Infection Research Initiative supported by the Medical Research Council (Grant Number G0901608) with contributions from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research.

  • Ethics approval London-Bromley REC reference 15/LO/1929. Approval Number: IRAS Project ID 188077.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement A complete breakdown of the data is available from AB.